Jean-Paul Kress holds the position of Chairman of ERYTech Pharma SA, CEO & Chairman-Management Board at MorphoSys AG and President & Director at Syntimmune, Inc.

In the past Dr. Kress held the position of President-International & Executive Vice President at Biogen, Inc., President & Chief Executive Officer for Sanofi Pasteur MSD SNC and Senior Vice President & Head-North America at Genzyme Corp.

He received an undergraduate degree and a graduate degree from École Normale Supérieure and a doctorate from Faculté De Médecine Necker Enfants Malades Université.